Springer Nature's AdisInsight-into-Claude integration is the second major publisher-LLM embedding story this week (alongside Scite's Claude Connector). Together they signal an accelerating trend: major scholarly publishers are repositioning their databases as AI knowledge infrastructure — plugging into LLMs rather than competing with them. For SN, the pharma intelligence angle (drug pipeline data) is strategically significant: this is premium institutional content being routed through Claude as an interface layer. Important for P2P Review's ongoing tracking of publisher-AI relationships.

Source: KnowledgeSpeak